Overcoming the 'ick' factor: Why some big names find value in this company

Some big-name investors are betting they'll get more than they paid for out of shares of troubled Valeant Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.